Click to Share

Drug Development Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By InvitroCue Pte Ltd
InvitroCue and HD Biosciences Enter Collaboration Agreement for the Validation of Image Analysis Tools for Preclinical Drug Discovery
By SMi Group Ltd
SMi Reports: Britain was looking to accelerate access to drugs for patients with rare diseases when it launched the Early Access to Medicines Initiative in March this year. This initiative will be extremely beneficial for patients.
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
By Crown Bioscience
HuTrialTM demonstrates commitment to furthering preclinical understanding in order to improve personal care and increase patient recovery rates
By SMi Group Ltd
Returning for its fitfth year and following on from the major success of previous events, SMI are proud to present the 5th annual Biosimilars & Biobetters Conference, 29th-30th September, 2014, London.
By Online Compliance Panel LLC
Know the complete details, key strategies, regulatory considerations, and marketing strategies for developing 505(b)(2) products
By Calvert Holdings, Inc.
Calvert Holdings, Inc. announced that Michael A. Recny, Ph.D., has been appointed Chief Executive Officer and has been elected a Director of the Company.
By Cambridge Healthtech Institute
Moderated by Freeslate, Inc., Mercer University, Johnson & Johnson, and the University of Miami Miller School of Medicine
By Calvert Holdings, Inc.
Calvert Research, LLC, a business unit of Calvert Holdings, Inc., announced that the U.S.
By SMi Group
"Adaptive clinical trials might be globally embraced if the current preoccupation with fixed trial designs was viewed as an “engineering problem” requiring a lot of talk and teamwork between adaptive design experts", said Michael Krams, MD, vice...
By Quotient Clinical
Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum.
By KDM Communications
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
By Calvert Holdings, Inc.
Calvert Research and Oncoceutics announced today an investment partnership to support the completion of preclinical development for ONC201, Oncoceutics' preclinical stage experimental anti-cancer compound.
By Cayman Chemical Company
Cayman Chemical announces a partnership with ΔTm Technologies LLC, to develop a series of macromolecular analysis kits that provide a rapid, sensitive, and economical method for assessing both protein stability and protein-ligand interactions using...
By Calvert Holdings, Inc.
Scott Township, PA – June 10, 2013 – Calvert Labs and EyeCRO, two leading providers in early-stage ocular drug research and development, announced today that they have entered into a strategic partnership to expedite preclinical drug development...
By Rosa & Co
PhysioPD™ modeling collaboration in psoriasis to be presented May 20-22, 2013.
By Rosa & Co
Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013.
By Mary Ann Liebert, Inc., publishers
New Rochelle, May 16, 2013–Lethal and rescuer genes are defined as genes that when inactivated result in cell death or enhanced cell growth, respectively.
By Veristat
Collaboration offers clients more streamlined and efficient approach to trial planning
By Mary Ann Liebert, Inc., publishers
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside.
By SMi Group Ltd
Adaptive Designs in Clinical Trials to take place in London, UK, 8th & 9th April...
By Cambridge Healthtech Institute
Mar. 20, 2013 - Needham, MA - Part of Cambridge Healthtech Institute’s Bio-IT World Expo, attendees will gain first-hand insight from three plenary keynote presentations, aligned with the event theme of new trends in data generation, knowledge...
By Cures Within Reach
Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and...
By Calvert Holdings, Inc.
Scott Township, PA – Calvert Laboratories and Particle Sciences, two leading companies in their respective fields of preclinical toxicology and drug product formulation, announced today that they have joined forces to offer a streamlined solution to...
By cardiabase
CardiaBase, a global provider of centralized diagnostic services to clinical trials, is pleased to announce that Dr. Pierre Maison-Blanche joined the company as Chief Medical Officer.
By Cambridge Healthtech Institute
Plenary Keynote Panels on "Personalized Oncology: Fulfilling the Promise for Today’s Patients" and "Emerging Technologies & Industry Perspectives" to be Delivered Next Month in San Francisco
By SMi Group
Imaging in Cancer Drug Development taking place in London, March 2013, focuses on current developments surrounding oncology imaging and overcoming chemical challenges in radiotracer development.
By Cambridge Healthtech Institute
Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference
By Cambridge Healthtech Institute
Cambridge Healthtech Institute's Patient-Derived Cancer Tissue Xenograft Models Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.
By Adaptive Clinical Systems
ACRIM, a leading imaging Contract Research Organization (iCRO), has selected Adaptive Clinical Systems’ Cloud-based e-Clinical solution for its EDC needs.

Page updated every 10 minutes

Like PRLog?
Click to Share